SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-25-067322 from Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223) (KLTO)

Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223)
Date: July 24, 2025 · CIK: 0001907223 · Accession: 0001213900-25-067322

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288533

Date
July 24, 2025
Author
/s/ Joseph Sinkule
Form
CORRESP
Company
Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223)

Letter

RE: Klotho Neurosciences, Inc. (the "Company")

KLOTHO NEUROSCIENCES, INC.

July 24, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Registration Statement on Form S-3

File No. 333-288533 (the "Registration Statement")

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Klotho Neurosciences, Inc. (the "Company") hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. ET on Friday, July 25, 2025, or as soon thereafter as is practicable, unless we or our outside counsel, Paul Goodman request by telephone that such Registration Statement be declared effective at some other time.

Please direct any questions regarding this filing to Paul Goodman, Esq at 917-596-0905.

Very truly yours,
By:
/s/ Joseph Sinkule

Show Raw Text
CORRESP
 1
 filename1.htm

 KLOTHO NEUROSCIENCES, INC.

 July 24, 2025

 VIA EDGAR

 Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, DC 20549

 RE:
 Klotho Neurosciences, Inc. (the "Company")

 Registration Statement on Form S-3

 File No. 333-288533 (the "Registration Statement")

 Ladies and Gentlemen:

 In accordance with Rule 461 under the Securities
Act of 1933, as amended, Klotho Neurosciences, Inc. (the "Company") hereby respectfully requests that the effective date of
the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. ET on Friday, July 25,
2025, or as soon thereafter as is practicable, unless we or our outside counsel, Paul Goodman request by telephone that such Registration
Statement be declared effective at some other time.

 Please direct any questions regarding this filing
to Paul Goodman, Esq at 917-596-0905.

 Very truly yours,

 By:
 /s/ Joseph Sinkule

 Name:
 Joseph Sinkule

 Title:
 Chief Executive Officer